• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰弱对急性肢体缺血患者血管重建术后截肢、死亡和活动能力的预测作用。

Predictive Effect of Frailty on Amputation, Mortality, and Ambulation in Patients Undergoing Revascularization for Acute Limb Ischemia.

机构信息

Division of Vascular Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.

Division of Vascular Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.

出版信息

Ann Vasc Surg. 2021 May;73:273-279. doi: 10.1016/j.avsg.2020.10.048. Epub 2020 Dec 17.

DOI:10.1016/j.avsg.2020.10.048
PMID:33340668
Abstract

BACKGROUND

Frailty is a common, age-associated syndrome that has been used to predict postoperative outcomes in vascular surgery. This study examines if standard measures of frailty correlate with postoperative outcomes for patients undergoing revascularization for acute limb ischemia (ALI).

METHODS

A retrospective study was conducted on all adult patients undergoing revascularization for ALI at an academic medical center between January 2016 and June 2019. Frailty was calculated with the 11-factor modified frailty index (mFI-11), derived from the Canadian Study of Health and Aging Frailty Index. Outcomes examined included in-hospital mortality, major amputation, site of discharge, and ambulatory status at follow-up.

RESULTS

Fifty-three ambulatory patients presented with ALI during the study time period, with 13.2% deemed not frail (mFI-11 < 3) and 86.8% deemed frail (mFI-11 ≥ 3). Frailty was significantly correlated with discharge to a skilled nursing facility (P = 0.028) and nonambulation at follow-up (P = 0.002). There was no significant correlation with other outcomes, including mortality and amputation. On multivariate analysis, frailty was the only factor contributing to nonambulation at follow-up (P = 0.012). Endovascular treatment did not mitigate the effects of frailty on discharge site and ambulatory status.

CONCLUSIONS

Frailty is exceedingly common in patients with ALI. Although frailty predicts discharge site and nonambulation at follow-up, it is not associated with amputation or death. Therefore, frail patients should not be denied open or endovascular revascularization for ALI.

摘要

背景

衰弱是一种常见的与年龄相关的综合征,已被用于预测血管外科学术后结果。本研究探讨了在学术医疗中心接受急性肢体缺血(ALI)血运重建的患者中,标准衰弱测量指标与术后结果是否相关。

方法

对 2016 年 1 月至 2019 年 6 月期间在学术医疗中心接受 ALI 血运重建的所有成年患者进行回顾性研究。采用源自加拿大健康老龄化衰弱指数的 11 因素改良衰弱指数(mFI-11)计算衰弱程度。评估的结果包括院内死亡率、大截肢、出院地点和随访时的步行状态。

结果

研究期间共有 53 例可活动的患者出现 ALI,其中 13.2%被认为不衰弱(mFI-11<3),86.8%被认为衰弱(mFI-11≥3)。衰弱与入住疗养院(P=0.028)和随访时不能行走(P=0.002)显著相关。与其他结果(包括死亡率和截肢)无显著相关性。多变量分析显示,衰弱是导致随访时不能行走的唯一因素(P=0.012)。血管内治疗并不能减轻衰弱对出院地点和步行状态的影响。

结论

ALI 患者衰弱非常常见。尽管衰弱预测出院地点和随访时不能行走,但与截肢或死亡无关。因此,不应拒绝衰弱的 ALI 患者进行开放或血管内血运重建。

相似文献

1
Predictive Effect of Frailty on Amputation, Mortality, and Ambulation in Patients Undergoing Revascularization for Acute Limb Ischemia.衰弱对急性肢体缺血患者血管重建术后截肢、死亡和活动能力的预测作用。
Ann Vasc Surg. 2021 May;73:273-279. doi: 10.1016/j.avsg.2020.10.048. Epub 2020 Dec 17.
2
Impact of Frailty on Clinical Outcomes in Patients With Critical Limb Ischemia.衰弱对重症肢体缺血患者临床结局的影响。
Circ Cardiovasc Interv. 2018 Jul;11(7):e006778. doi: 10.1161/CIRCINTERVENTIONS.118.006778.
3
The Modified Frailty Index Does Not Predict Mortality After Major Lower Extremity Amputation for Peripheral Arterial Disease in an Asian Population.改良衰弱指数不能预测亚洲人群下肢主要截肢术后外周动脉疾病的死亡率。
Ann Vasc Surg. 2020 Nov;69:298-306. doi: 10.1016/j.avsg.2020.05.063. Epub 2020 Jun 4.
4
Predictors of poor outcomes after lower extremity revascularization for acute limb ischemia.下肢动脉血运重建治疗急性肢体缺血不良结局的预测因素。
Vascular. 2024 Jun;32(3):632-639. doi: 10.1177/17085381231154290. Epub 2023 Jan 25.
5
Associations of Clinical Frailty with Severity of Limb Threat and Outcomes in Chronic Limb-threatening Ischaemia.临床虚弱与肢体威胁严重程度及慢性肢体威胁性缺血结局的关联。
Ann Vasc Surg. 2021 Oct;76:406-416. doi: 10.1016/j.avsg.2021.04.017. Epub 2021 May 2.
6
Influence of frailty on treatment outcomes after revascularization in patients with critical limb ischemia.衰弱对严重肢体缺血患者血管重建术后治疗结局的影响。
J Vasc Surg. 2017 Dec;66(6):1758-1764. doi: 10.1016/j.jvs.2017.04.048. Epub 2017 Jun 21.
7
Analysis of the results of endovascular and open surgical treatment of acute limb ischemia.分析急性肢体缺血的腔内治疗和开放手术治疗的结果。
J Vasc Surg. 2019 Mar;69(3):843-849. doi: 10.1016/j.jvs.2018.07.056. Epub 2019 Jan 22.
8
Modified Frailty Index Can Be Used to Predict Adverse Outcomes and Mortality after Lower Extremity Bypass Surgery.改良虚弱指数可用于预测下肢旁路手术后的不良结局和死亡率。
Ann Vasc Surg. 2018 Jan;46:168-177. doi: 10.1016/j.avsg.2017.07.007. Epub 2017 Jul 21.
9
Early Outcomes following Endovascular, Open Surgical, and Hybrid Revascularization for Lower Extremity Acute Limb Ischemia.下肢急性肢体缺血的血管内治疗、开放手术治疗和杂交血运重建后的早期疗效
Ann Vasc Surg. 2018 Aug;51:106-112. doi: 10.1016/j.avsg.2017.12.025. Epub 2018 Mar 5.
10
Endovascular Management of Chronic Limb-Threatening Ischemia (CLTI) in the Elderly: A Focus on Frailty, Wound Healing, and Outcomes.老年慢性肢体缺血性疾病(CLTI)的血管内治疗:关注虚弱、伤口愈合和结局。
Ann Vasc Surg. 2024 Sep;106:321-332. doi: 10.1016/j.avsg.2024.03.014. Epub 2024 May 28.

引用本文的文献

1
Decision making in the frail vascular surgery patient: A scoping review.虚弱血管手术患者的决策制定:范围综述。
Semin Vasc Surg. 2024 Jun;37(2):224-239. doi: 10.1053/j.semvascsurg.2024.04.003. Epub 2024 Apr 21.
2
Frailty score and outcomes of patients undergoing vascular surgery and amputation: A systematic review and meta-analysis.血管手术和截肢患者的衰弱评分与预后:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2023 Jan 25;10:1065779. doi: 10.3389/fcvm.2023.1065779. eCollection 2023.
3
HIV and Aging: Overcoming Challenges in Existing HIV Guidelines to Provide Patient-Centered Care for Older People with HIV.
艾滋病毒与老龄化:克服现有艾滋病毒指南中的挑战,为老年艾滋病毒感染者提供以患者为中心的护理。
Pathogens. 2021 Oct 15;10(10):1332. doi: 10.3390/pathogens10101332.